BACKGROUND:Chromium is an essential trace element and nutritional supplement that has garnered interest for use as a weight loss aid. OBJECTIVE: This trial assesses the effects of chromium picolinate supplementation, alone and combined with nutritional education, on weight loss in apparently healthy overweight adults. DESIGN: This was a randomized, double-blind, placebo-controlled trial of 80 otherwise healthy, overweight adults assessed at baseline for central adiposity measured by computerized tomography. Subjects were randomly assigned to daily ingestion of 1000 microg of chromium picolinate or placebo for 24 weeks. All subjects received passive nutritional education at the 12-week point in both the intervention and control groups. Outcomes include weight, height, blood pressure, percent body fat, serum, and urinary biomarkers. RESULTS: At baseline, both the chromium and placebo groups had similar mean body mass index (BMI) (chromium = 36 +/- 6.7 kg/m(2) versus placebo = 36.1 +/- 7.6 kg/m(2); p = 0.98). After 12 weeks, no change was seen in BMI in the intervention as compared to placebo (chromium = 0.3 +/- 0.8 kg/m(2) versus placebo = 0.0 +/- 0.4 kg/m(2); p = 0.07). No change was seen in BMI after 24 weeks in the intervention as compared to placebo (chromium = 0.1 +/- 0.2 kg/m(2) versus placebo = 0.0 +/- 0.5 kg/m(2); p = 0.81). Variation in central adiposity did not affect any outcome measures. CONCLUSIONS: Supplementation of 1000 microg of chromium picolinate alone, and in combination with nutritional education, did not affect weight loss in this population of overweight adults. Response to chromium did not vary with central adiposity.
RCT Entities:
BACKGROUND:Chromium is an essential trace element and nutritional supplement that has garnered interest for use as a weight loss aid. OBJECTIVE: This trial assesses the effects of chromium picolinate supplementation, alone and combined with nutritional education, on weight loss in apparently healthy overweight adults. DESIGN: This was a randomized, double-blind, placebo-controlled trial of 80 otherwise healthy, overweight adults assessed at baseline for central adiposity measured by computerized tomography. Subjects were randomly assigned to daily ingestion of 1000 microg of chromium picolinate or placebo for 24 weeks. All subjects received passive nutritional education at the 12-week point in both the intervention and control groups. Outcomes include weight, height, blood pressure, percent body fat, serum, and urinary biomarkers. RESULTS: At baseline, both the chromium and placebo groups had similar mean body mass index (BMI) (chromium = 36 +/- 6.7 kg/m(2) versus placebo = 36.1 +/- 7.6 kg/m(2); p = 0.98). After 12 weeks, no change was seen in BMI in the intervention as compared to placebo (chromium = 0.3 +/- 0.8 kg/m(2) versus placebo = 0.0 +/- 0.4 kg/m(2); p = 0.07). No change was seen in BMI after 24 weeks in the intervention as compared to placebo (chromium = 0.1 +/- 0.2 kg/m(2) versus placebo = 0.0 +/- 0.5 kg/m(2); p = 0.81). Variation in central adiposity did not affect any outcome measures. CONCLUSIONS: Supplementation of 1000 microg of chromium picolinate alone, and in combination with nutritional education, did not affect weight loss in this population of overweight adults. Response to chromium did not vary with central adiposity.
Authors: Julie Martin; Zhong Q Wang; Xian H Zhang; Deborah Wachtel; Julia Volaufova; Dwight E Matthews; William T Cefalu Journal: Diabetes Care Date: 2006-08 Impact factor: 19.112
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Stephen D Anton; Christopher D Morrison; William T Cefalu; Corby K Martin; Sandra Coulon; Paula Geiselman; Hongmei Han; Christy L White; Donald A Williamson Journal: Diabetes Technol Ther Date: 2008-10 Impact factor: 6.118
Authors: Karla V G Lima; Raquel P A Lima; Maria C R Gonçalves; Joel Faintuch; Liana C S L Morais; Luiza S R Asciutti; Maria J C Costa Journal: Obes Surg Date: 2014-05 Impact factor: 4.129
Authors: Kimberly A Brownley; Ann Von Holle; Robert M Hamer; Maria La Via; Cynthia M Bulik Journal: J Psychosom Res Date: 2013-04-22 Impact factor: 3.006
Authors: John A Batsis; John W Apolzan; Pamela J Bagley; Heather B Blunt; Vidita Divan; Sonia Gill; Angela Golden; Shalini Gundumraj; Steven B Heymsfield; Scott Kahan; Katherine Kopatsis; Ava Port; Elizabeth Prout Parks; Clifford A Reilly; Domenica Rubino; Katherine H Saunders; Ryan Shean; Luai Tabaza; Abishek Stanley; Beverly G Tchang; Shivani Gundumraj; Srividya Kidambi Journal: Obesity (Silver Spring) Date: 2021-07 Impact factor: 9.298